Navigation Links
Following Heart Disease Guidelines Saves Lives, According to a Kaiser Permanente Abstract Presented at AHA Scientific Sessions
Date:11/4/2007

OAKLAND, Calif., Nov. 4 /PRNewswire/ -- Consistent implementation of proven Heart Disease guidelines can save lives, according to a Kaiser Permanente (KP) abstract, published this week at the American Heart Association Scientific Sessions in Orlando, Florida.

The researchers followed 598 patients with Acute Coronary Syndromes (ACS) admitted to Kaiser Permanente emergency departments in Northern California and examined whether they received any of six key interventions included in American College of Cardiology/American Heart Association Guidelines(1) that are known to decrease deaths from ACS. The results were then compared with data for ACS patients admitted to non-KP emergency departments, gathered by the National Registry of Myocardial Infarction (NRMI) and CRUSADE(2).

Overall, more Kaiser Permanente patients received the recommended therapies in every case. For example, 92 per cent of Kaiser Permanente patients with ACS were discharged with an ACE inhibitor(3) or angiotensin-receptor blocker (ARB)(4), recommended in the guidelines as an effective therapy for reducing mortality from heart attacks. By comparison, only 61 per cent of eligible patients in non-KP hospitals in the CRUSADE database and 55 per cent in the NRMI database received an ACE inhibitor or ARB. On admission, 97 per cent of eligible KP patients received beta blockers compared with 74 per cent in NRMI.

Kaiser Permanente Northern California has been systematically implementing the National Clinical Guidelines since the 1990s. Study co-author Eleanor Levin, MD explained that cardiologists and emergency physicians used the guidelines to develop protocols and standardized admit and discharge orders for treating ACS patients.

"Following the guidelines in KP Northern California has been so successful because four departments -- cardiology, quality, emergency medicine, and hospital-based specialists -- have worked closely together to implement protocols and orders for heart disease patients," said Dr. Levin. "We can achieve that kind of effective collaboration because we are an integrated health care organization. Our patients benefited immediately in a very real way -- the number of deaths caused by heart disease among KP Northern California members has been falling consistently since 1995. We hope that these results will encourage other health care organizations to improve implementation of the clinical guidelines and save lives," she said.

The six key therapies and interventions recommended by the National Clinical Guidelines are:

Once ACS is confirmed in the ED, the following medications should be

given:

1. Aspirin, and

2. Beta Blockers

On discharge, patients should receive:

3. Aspirin

4. Beta Blockers, and

5. An ACE(4) inhibitor or ARB(5) and,

6. Advice on quitting smoking for patients who are smokers

About Kaiser Permanente

Kaiser Permanente, founded in 1945, is a non-profit integrated health care organization, with physicians, nurses and staff working in collaboration to provide high quality care to patients and to address the health care needs of communities served by the organization. The Kaiser Permanente Northern California Region serves more than 3.2 million members. It includes 6,000 physicians in The Permanente Medical Group (TPMG) and about 66,000 employees. The region has 19 major medical centers. Each year, Kaiser Permanente donates about $375 million to a variety of community programs and agencies in Northern California.

http://www.kaiserpermanente.org

NOTES

(1) ACC/AHA Guidelines are updated and published on the American Heart

Association web site.

(2) As of January 2007, CRUSADE (Can Rapid Risk Stratification of

Unstable Angina Patients Suppress Adverse Outcomes with Early

Implementation of ACC/AHA Guidelines) merged with the NRMI (National

Registry of Myocardial Infarction) to form the ACTION (Acute Coronary

Treatment and Intervention Outcomes Network) registry.

(3) ACE inhibitors, or inhibitors of angiotensin-converting enzyme, are a

group of pharmaceuticals that are used to treat high blood pressure

and congestive heart failure.

(4) An Angiotensin receptor blocker (ARB) is a medication that blocks the

action of angiotensin II, permitting the blood vessels to relax and

dilate, which lowers the blood pressure. ARBs have effects similar

to those of ACE inhibitors, and are often used when an ACE inhibitor

cannot be tolerated by patients.


'/>"/>
SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Spurt in hospital admissions following football shoot-outs
2. Weight gain following smoking cessation not linked to Leptin
3. Anxiety following heart attacks not adequately managed
4. Reducing Disabilities By Following A Healthy Diet
5. Attention! Spells of momentary blindness following visual disturbance
6. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
7. Avenues to opened for medical tourists following relaxation of visa regulations
8. People seek reassurance in facemasks following threats of bird flu epidemic
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Death Of Woman Following Family Planning Operation Creates Panic
11. Boy Refused Compensation For HIV Infection Following Hospital Admission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology: